FDA Penalizes Mammography Center

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 7 No 10
Volume 7
Issue 10

ROCKVILLE, Md--A Chicago mammography facility, known as CMI, has agreed to pay a $30,000 fine and to cease operating in the mammography field for 5 years. The FDA had accused it of performing mammography exams without

ROCKVILLE, Md--A Chicago mammography facility, known as CMI, has agreed to pay a $30,000 fine and to cease operating in the mammography field for 5 years. The FDA had accused it of performing mammography exams without accreditation, a violation of the Mammography Quality Standards Act of 1992. Both CMI and its president, Thomas E. Miller, will remove themselves from the mammography field and jointly pay $25,000. The facility’s supervisory radiologist will pay $5,000. The case is the first time a mammography facility has been required to pay a civil money penalty under the Act.

Recent Videos
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Related Content